Who owns INCY? 13F holders and whale ownership
INCY is tracked across public portfolios in Whale Analyzer. This page answers who owns INCY, which top funds are buying INCY, aggregate disclosed value, and recent position changes based on public data. Baker Bros. Advisors is the largest reported holder at $2.89B; the top five funds control 100.0% of reported ownership; institutions were net selling last quarter (1 increased, 1 reduced); the stock trades above the aggregate whale cost basis of $73.0. Top tracked holders include Baker Bros. Advisors and Dodge & Cox.
Continue to the live INCY dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Baker Bros. Advisors 13F portfolio Baker Bros. Advisors holdings | $2.89B | 30.7M | Increased |
| Dodge & Cox 13F portfolio Dodge & Cox holdings | $1.15B | 12.3M | Reduced |
Ownership concentration
Reported ownership of INCY is highly concentrated across tracked institutions.
- Single largest holder: 71.5% of reported ownership
- Top 5 holders: 100.0%
- Top 10 holders: 100.0%
Whale activity this quarter
Across 2 tracked institutions, 1 increased, 1 reduced. Net positioning is net selling.
- Baker Bros. Advisors — Baker Bros. Advisors ($2.89B) (→ 0.0% qoq shares)
- Dodge & Cox — Dodge & Cox ($1.15B) (▼ 7.6% qoq shares) · avg cost $73.00
Whale cost basis vs current price
The aggregate tracked cost basis is $73.00 versus a current price of $113.75, so INCY trades above its cost basis (+55.8%). Average unrealized P&L across tracked holders: 33%.
Sector positioning — Health Care
INCY sits within the Health Care sector alongside 221 other tracked names. Compare whale ownership across peers:
How to use this page
Values are reported public positions from tracked 13F filers and disclosures — not real-time ownership totals. Open the live INCY dashboard for price charts and cross-investor scans, or read the SEC 13F guide.
Related stock holder pages
- BEIGF whale holders — BeOne Medicines Ltd.
- INSM whale holders — Insmed Incorporated
- MDGL whale holders — Madrigal Pharmaceuticals, Inc.
- ACAD whale holders — ACADIA Pharmaceuticals Inc.
- RVMDW whale holders — Revolution Medicines, Inc.
- CELC whale holders — Celcuity Inc.
- KOD whale holders — Kodiak Sciences Inc.
- KYMR whale holders — Kymera Therapeutics, Inc.
Learn more in Whale Analyzer Academy
Deepen your read on INCY with these Whale Analyzer Academy guides:
Frequently asked questions
Who owns INCY stock?
Whale Analyzer tracks 2 public institutional holders of INCY with a combined reported value of $4.05B. See the holder table above for the largest tracked positions.
Which top funds are buying INCY?
Tracked institutions were net selling last quarter — 1 increased, 1 reduced. Check the "Change" column: "New" = fresh position, "Increased" = added, "Reduced" = trimmed.
How concentrated is INCY ownership?
The top five tracked holders report 100.0% of aggregate ownership.
Is INCY above or below the whale cost basis?
The aggregate tracked cost basis is $73.00 versus a current price of $113.75 (+55.8%).
What does 13F ownership mean for INCY?
Use the interactive INCY dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.